» Articles » PMID: 19140135

Modeling the Interaction Between the N-terminal Domain of the Tumor Suppressor P53 and Azurin

Overview
Journal J Mol Recognit
Specialty Molecular Biology
Date 2009 Jan 14
PMID 19140135
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

It is known that the half life of the tumor suppressor p53 can be increased by the interaction with the bacterial protein azurin, resulting in an enhanced anti-tumoral activity. The understanding of the molecular mechanisms on the basis of this phenomenon can open the way to new anti-cancer strategies. Some experimental works have given evidence of an interaction between p53 and azurin (AZ); however the binding regions of the proteins are still unknown. Recently, fluorescence studies have shown that p53 partakes in the binding with the bacterial protein by its N-terminal (NT) domain. Here we have used a computational method to get insight into this interacting mode. The model that we propose for the best complex between AZ and p53 has been obtained from a rigid-body docking, coupled with a molecular dynamics (MD) simulation, a free energy calculation, and validated by mutagenesis analysis. We have found a high degree of geometric fit between the two proteins that are kept together by several hydrophobic interactions and numerous hydrogen bonds. Interestingly, it has emerged that AZ binds essentially to the helices H(I) and H(III) of the p53 NT domain, which are also interacting regions for the foremost inhibitor of p53, MDM2.

Citing Articles

Interaction between miR4749 and Human Serum Albumin as Revealed by Fluorescence, FRET, Atomic Force Spectroscopy and Computational Modelling.

Botti V, Marrone S, Cannistraro S, Bizzarri A Int J Mol Sci. 2022; 23(3).

PMID: 35163220 PMC: 8835948. DOI: 10.3390/ijms23031291.


Investigation of a Direct Interaction between miR4749 and the Tumor Suppressor p53 by Fluorescence, FRET and Molecular Modeling.

Bizzarri A, Cannistraro S Biomolecules. 2020; 10(2).

PMID: 32098369 PMC: 7072324. DOI: 10.3390/biom10020346.


Perturbing the Dynamics and Organization of Cell Membrane Components: A New Paradigm for Cancer-Targeted Therapies.

Bernardes N, Fialho A Int J Mol Sci. 2018; 19(12).

PMID: 30518103 PMC: 6321595. DOI: 10.3390/ijms19123871.


Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.

Gao M, Zhou J, Su Z, Huang Y Protein Sci. 2017; 26(12):2334-2341.

PMID: 28960574 PMC: 5699490. DOI: 10.1002/pro.3310.


Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53.

Nguyen C, Nguyen V Biomed Res Int. 2016; 2016:8490482.

PMID: 27239476 PMC: 4867070. DOI: 10.1155/2016/8490482.